Mankind Pharma on Tuesday said it has collaborated with South Korean firm Daewoong Pharmaceutical Co for conducting phase-I clinical trial of a novel formulation of Niclosamide for the treatment of COVID-19 patients in India. The trial is designed towards addressing the need for an investigation on this new formulation based on encouraging pre-clinical evidence for the treatment of COVID-19, Mankind …
)